Recent studies support neurogranin, a postsynaptic neuron-specific protein, as a CSF marker of synaptic degeneration in AD (Kvartsberg et al., 2015b; Portelius et al., 2018). The gene discussed is NRGN; the disease is Alzheimer disease.